HylS’, a fragment of truncated hyaluronidase of Streptococcus suis, contributes to immune evasion by interaction with host complement factor C3b

References

• Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol. 2013;190(8):3831–16. doi: 10.4049/jimmunol.1203487
   PubMed Web of Science ®Google Scholar
• Ricklin D, Reis ES, Mastellos DC, et al. Complement component C3 – the “Swiss army knife” of innate immunity and host defense. Immunol Rev. 2016;274(1):33–58. doi: 10.1111/imr.12500
   PubMed Web of Science ®Google Scholar
• Reichhardt MP, Merib S. Intracellular complement activation—An alarm raising mechanism? Semin Immunol. 2018;38:54–62. doi: 10.1016/j.smim.2018.03.003
   PubMed Web of Science ®Google Scholar
• Rambach G, Wurzner R, Speth C. Complement: an efficient sword of innate immunity. Contrib Microbiol. 2008;15:78–100. doi: 10.1159/000136316
   PubMedGoogle Scholar
• Sarma JV, Ward PA. The complement system. Cell Tissue Res. 2011;343(1):227–235. doi: 10.1007/s00441-010-1034-0
   PubMed Web of Science ®Google Scholar
• Ricklin D, Hajishengallis G, Yang K, et al. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785–797. doi: 10.1038/ni.1923
   PubMed Web of Science ®Google Scholar
• Gadjeva M. The complement system. Overview. Methods Mol Biol. 2014;1100:1–9. doi: 10.1007/978-1-62703-724-2_1
   PubMedGoogle Scholar
• Sharma S, Bhatnagar R, Gaur D. Complement evasion strategies of human pathogenic bacteria. Indian J Microbiol. 2020;60(3):283–296. doi: 10.1007/s12088-020-00872-9
   PubMed Web of Science ®Google Scholar
• Bajic G, Yatime L, Sim RB, et al. Structural insight on the recognition of surface bound opsonin by integrin I domain of complement receptor 3. Proc Natl Acad Sci, USA. 2013;110(41):16426–16431. doi: 10.1073/pnas.1311261110
   PubMed Web of Science ®Google Scholar
• Haupt K, Reuter M, van den Elsen J, et al. The Staphylococcus aureus protein sbi acts as a complement inhibitor and forms a tripartite complex with host complement factor H and C3b. PLoS Pathog. 2008;4(12):e1000250. doi: 10.1371/journal.ppat.1000250
   PubMed Web of Science ®Google Scholar
• Dasari P, Nordengrun M, Vilhena C, et al. The protease SplB of Staphylococcus aureus targets host complement components and inhibits complement-mediated bacterial opsonophagocytosis. J Bacteriol. 2021;204(1):e00184–21. JB0018421. doi: 10.1128/JB.00184-21
   PubMed Web of Science ®Google Scholar
• Ramos-Sevillano E, Urzainqui A, Campuzano S, et al. Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response. Infect Immun. 2015;83(2):591–603. doi: 10.1128/IAI.02811-14
   PubMed Web of Science ®Google Scholar
• Zheng H, Qiu X, Roy D, et al. Genotyping and investigating capsular polysaccharide synthesis gene loci of non-serotypeable Streptococcus suis isolated from diseased pigs in Canada. Vet Res. 2017;48(1):10. do i:
   PubMedGoogle Scholar
• Gottschalk M, Xu J, Calzas C, et al. Streptococcus suis: a new emerging or an old neglected zoonotic pathogen? Future Microbiol. 2010;5(3):371–391. doi: 10.2217/fmb.10.2
   Google Scholar
• Yu H, Jing H, Chen Z, et al. Human Streptococcus suis outbreak, Sichuan, China. Emerg Infect Dis. 2006;12(6):914–920. doi: 10.3201/1206.051194
   PubMed Web of Science ®Google Scholar
• Mai NT, Hoa NT, Nga TV, et al. Streptococcus suis meningitis in adults in Vietnam. Clin Infect Dis. 2008;46(5):659–667. doi: 10.1128/.00417-22
   PubMed Web of Science ®Google Scholar
• Staats JJ, Feder I, Okwumabua O, et al. Streptococcus suis: past and present. Vet Res Commun. 1997;21(6):381–407. doi: 10.1023/A:1005870317757
   PubMed Web of Science ®Google Scholar
• Gottschalk M, Segura M. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet Microbiol. 2000;76:259–272. doi: 10.1016/S0378-1135(00)00250-9
   PubMed Web of Science ®Google Scholar
• Lecours MP, Gottschalk M, Houde M, et al. Critical role for streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells. J Infect Dis. 2011;204(6):919–929. doi: 10.1093/infdis/jir415
   PubMed Web of Science ®Google Scholar
• Deng SM, Xu T, Fang Q, et al. The surface-exposed protein SntA contributes to complement evasion in zoonotic Streptococcus suis. Front Immunol. 2018;9:1063–1063. doi: 10.3389/fimmu.2018.01063
   PubMed Web of Science ®Google Scholar
• Liu P, Pian Y, Li X, et al. Streptococcus suis adenosine synthase functions as an effector in evasion of PMN-mediated innate immunity. J Infect Dis. 2014;210(1):35–45. doi: 10.1128/.00417-22
   PubMed Web of Science ®Google Scholar
• Dai J, Lai L, Tang H, et al. Streptococcus suis synthesizes deoxyadenosine and adenosine by 5’-nucleotidase to dampen host immune responses. Virulence. 2018;9(1):1509–1520. doi: 10.1080/21505594.2018.1520544
   PubMed Web of Science ®Google Scholar
• Litwiniuk M, Krejner A, Speyrer MS, et al. Hyaluronic acid in inflammation and tissue regeneration. Wounds Compend Clin Res Pract. 2016;28:78–88.
   PubMed Web of Science ®Google Scholar
• Stern R, Jedrzejas MJ. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev. 2006;106(3):818–839. doi: 10.1021/cr050247k
   PubMed Web of Science ®Google Scholar
• Tao L, Song F, Xu N, et al. New insights into the action of bacterial chondroitinase AC I and hyaluronidase on hyaluronic acid. Carbohydr Polym. 2017;158:85–92. doi: 10.1016/j.carbpol.2016.12.010
   PubMed Web of Science ®Google Scholar
• Li S, Jedrzejas MJ. Hyaluronan binding and degradation by Streptococcus agalactiae hyaluronate lyase. J Biol Chem. 2001;276(44):41407–41416. doi: 10.1074/jbc.M106634200
   PubMed Web of Science ®Google Scholar
• Marion C, Stewart JM, Tazi MF, et al. Streptococcus pneumoniae can utilize multiple sources of hyaluronic acid for growth. Infect Immun. 2012;80(4):1390–1398. doi: 10.1128/IAI.05756-11
   PubMed Web of Science ®Google Scholar
• Ibberson CB, Jones CL, Singh S, et al. Staphylococcus aureus hyaluronidase is a CodY-regulated virulence factor. Infect Immun. 2014;82(10):4253–4264. doi: 10.1128/IAI.01710-14
   PubMed Web of Science ®Google Scholar
• Mullaney DM. Group B streptococcal infections in newborns. J ObstetGynecol Neonatal Nurs. 2001;30(6):649–658. doi: 10.1111/j.1552-6909.2001.tb00012.x
   PubMedGoogle Scholar
• Kothari NJ, Morin CA, Glennen A, et al. Invasive group B Streptococcal disease in the elderly, Minnesota, USA, 2003-2007. Emerg Infect Dis. 2009;15(8):1279–1281. doi: 10.3201/eid1508.081381
   PubMed Web of Science ®Google Scholar
• Francois Watkins LK, McGee L, Schrag SJ, et al. Epidemiology of invasive group B streptococcal infections among nonpregnant adults in the United States, 2008-2016. JAMA Intern Med. 2019;179(4):479–488. doi: 10.1128/spectrum.00417-22
   PubMed Web of Science ®Google Scholar
• Kolar SL, Kyme P, Tseng CW, et al. Group B Streptococcus evades host immunity by degrading hyaluronan. Cell Host Microbe. 2015;18(6):694–704. doi: 10.1128/spectrum.00417-22
   PubMed Web of Science ®Google Scholar
• Hynes WL, Walton SL. Hyaluronidases of gram-positive bacteria. FEMS Microbiol Lett. 2000;183(2):201–207. doi: 10.1111/j.1574-6968.2000.tb08958.x
   PubMed Web of Science ®Google Scholar
• Wang ZF, Guo CM, Xu YN, et al. Two novel functions of hyaluronidase from streptococcus agalactiae are enhanced intracellular survival and inhibition of proinflammatory cytokine expression. Infect Immun. 2014;82(6):2615–2625.
   PubMed Web of Science ®Google Scholar
• Wu T, Yuan FY, Chang HT, et al. Identification of a novel angiogenin inhibitor 1 and its association with hyaluronidase of Streptococcus suis serotype 2. Microbial Pathogenesis. 2010;49(1–2):32–37. doi: 10.1016/j.micpath.2010.03.002
   PubMed Web of Science ®Google Scholar
• Takamatsu D, Osaki M, Sekizaki T. Thermosensitive suicide vectors for gene replacement in Streptococcus suis. Plasmid. 2001;46(2):140–148. doi: 10.1006/plas.2001.1532
   PubMed Web of Science ®Google Scholar
• Takamatsu D, Osaki M, Sekizaki T. Construction and characterization of streptococcus suis–Escherichia coli shuttle cloning vectors. Plasmid. 2001;45(2):101–113. doi: 10.1006/plas.2000.1510
   PubMed Web of Science ®Google Scholar
• Zou G, Zhou J, Xiao R, et al. Effects of environmental and management-associated factors on prevalence and diversity of Streptococcus suis in clinically healthy pig herds in China and the United Kingdom. Appl Environ Microbiol. 2018;84(8):e02590–e02517. doi: 10.1128/AEM.02590-17
   PubMed Web of Science ®Google Scholar
• Smith RF, Willett NP. Rapid plate method for screening hyaluronidase and chondroitin sulfatase-producing microorganisms. Appl Environ Microbiol. 1968;16(9):1434–1436. doi: 10.1128/am.16.9.1434-1436.1968
   Google Scholar
• Palmer I, Wingfield PT. Preparation and extraction of insoluble (inclusion-body) proteins from Escherichia coli. Curr Protoc Protein Sci. 2012;70(1):6–3. doi: 10.1002/0471140864.ps0603s70
   Google Scholar
• Hardy CM, Mobbs KJ. Expression of recombinant mouse sperm protein sp56 and assessment of its potential for use as an antigen in an immunocontraceptive vaccine. Mol Reprod Dev. 1999;52:216–224. doi: 10.1002/(SICI)1098-2795(199902)52:2<216:AID-MRD13>3.0.CO;2-R
   PubMed Web of Science ®Google Scholar
• Stalhammar-Carlemalm M, Stenberg L, Lindahl G. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med. 1993;177(6):1593–1603. doi: 10.1084/jem.177.6.1593
   PubMed Web of Science ®Google Scholar
• McDevitt D, Francois P, Vaudaux P, et al. Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol. 1995;16:895–907. doi: 10.1111/j.1365-2958.1995.tb02316.x
   PubMed Web of Science ®Google Scholar
• Agarwal V, Sroka M, Fulde M, et al. Binding of Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence. J Biol Chem. 2014;289(22):15833–15844. do i:
   PubMed Web of Science ®Google Scholar
• Carlsson F, Berggard K, Stalhammarcarlemalm M, et al. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J Exp Med. 2003;198(7):1057–1068. doi: 10.1084/jem.20030543
   PubMed Web of Science ®Google Scholar
• Boero E, Brinkman I, Juliet T, et al. Use of flow cytometry to evaluate phagocytosis of Staphylococcus aureus by human neutrophils. Front Immunol. 2021;12:635825. doi: 10.3389/fimmu.2021.635825
   PubMed Web of Science ®Google Scholar
• Makris G, Wright JD, Ingham E, et al. The hyaluronate lyase of Staphylococcus aureus – a virulence factor? Microbiology. 2004;150(6):2005–2013. doi: 10.1099/mic.0.26942-0
   PubMedGoogle Scholar
• Hart ME, Hart MJ, Roop AJ. Genotypic and phenotypic assessment of hyaluronidase among type strains of a select group of staphylococcal species. Int J Microbiol. 2009;2009:614371. doi: 10.1155/2009/614371
   PubMedGoogle Scholar
• Yu YF, Wang J, Han R, et al. Mycoplasma hyopneumoniae evades complement activation by binding to factor H via elongation factor thermo unstable (EF-Tu). Virulence. 2020;11(1):1059–1074. do i:
   PubMed Web of Science ®Google Scholar
• Rooijakkers SH, van Strijp JA. Bacterial Complement Evasion. Mol Immunol. 2007;44(1–3):23–32. doi: 10.1016/j.molimm.2006.06.011
   PubMed Web of Science ®Google Scholar
• Lambris JD, Ricklin D, Geisbrecht BV. Complement evasion by human pathogens. Nat Rev Microbiol. 2008;6(2):132–42. doi: 10.1038/nrmicro1824
   PubMed Web of Science ®Google Scholar
• Blom AM, Hallstrom T, Riesbeck K. Complement evasion strategies of pathogens—acquisition of inhibitors and beyond. Mol Immunol. 2009;46(14):2808–2817. doi: 10.1016/j.molimm.2009.04.025
   PubMed Web of Science ®Google Scholar
• Baums CG, Kock K, Beineke A, et al. Streptococcus suis Bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9. Clin Vaccine Immunol. 2009;16(2):200–208. doi: 10.1128/CVI.00371-08
   PubMedGoogle Scholar
• Li XQ, Liu P, Gan SZ, et al. Mechanisms of host-pathogen protein complex formation and bacterial immune evasion of Streptococcus suis protein Fhb. J Biol Chem. 2016;291(33):17122–17132. doi: 10.1074/jbc.M116.719443
   PubMed Web of Science ®Google Scholar
• Li Q, Ma C, Fu Y, et al. Factor H specifically capture novel factor H-binding proteins of Streptococcus suis and contribute to the virulence of the bacteria. Microbiol Res. 2017 [cited 2016 Nov 24];196:17–25. doi: 10.1016/j.micres.2016.11.011
   PubMed Web of Science ®Google Scholar
• Deng SM, Zhao LY, Zhu JQ, et al. Complement C3aR/C5aR-binding protein Suilysin of Streptococcus suis contributes to monocyte chemotaxis. Vet Microbiol. 2020;242:108599. doi: 10.1016/j.vetmic.2020.108599
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yan K, Sun CF, et al. Binding of Plasminogen to Streptococcus suis Protein Endopeptidase O Facilitates Evasion of Innate Immunity in Streptococcus suis. Front Microbiol. 2021;12:694103. doi: 10.3389/fmicb.2021.694103
   PubMed Web of Science ®Google Scholar
• Rungelrath V, Weisse C, Schutze N, et al. IgM cleavage by Streptococcus suis reduces IgM bound to the bacterial surface and is a novel complement evasion mechanism. Virulence. 2018;9(1):1314–1337. doi: 10.1080/21505594.2018.1496778.
   PubMed Web of Science ®Google Scholar
• Gendrin C, Vornhagen J, Armistead B, et al. A nonhemolytic group B Streptococcus strain exhibits hypervirulence. J Infect Dis. 2018;217:983–987. doi: 10.1093/infdis/jix646
   PubMed Web of Science ®Google Scholar
• Zwijnenburg PJ, van der Poll T, Florquin S, et al. Experimental pneumococcal meningitis in mice: a model of intranasal infection. J Infect Dis. 2001;183:1143–1146. doi: 10.1086/319271
   PubMed Web of Science ®Google Scholar
• Haas B, Vaillancourt K, Bonifait L, et al. Hyaluronate lyase activity of Streptococcus suis serotype 2 and modulatory effects of hyaluronic acid on the bacterium’s virulence properties. BMC Res Notes. 2015;8(1):722–722. doi: 10.1186/s13104-015-1692-9
   PubMedGoogle Scholar
• King SJ, Allen AG, Maskell DJ, et al. Distribution, genetic diversity, and variable expression of the gene encoding hyaluronate lyase within the Streptococcus suis population. J Bacteriol. 2004;186(14):4740–4747. doi: 10.1128/JB.186.14.4740-4747.2004
   PubMed Web of Science ®Google Scholar
• Koch TK, Reuter M, Barthel D, et al. Staphylococcus aureus proteins Sbi and Efb recruit human plasmin to degrade complement C3 and C3b. PLoS One. 2012;7(10):e47638. doi: 10.1371/journal.pone.0047638
   PubMed Web of Science ®Google Scholar
• Jongerius I, Garcia BL, Geisbrecht BV, et al. Convertase inhibitory properties of staphylococcal extracellular complement-binding protein. J Biol Chem. 2010;285(20):14973–14979. doi: 10.1074/jbc.M109.091975
   PubMed Web of Science ®Google Scholar
• Marques MB, Kasper DL, Pangburn MK, et al. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B Streptococci. Infect Immun. 1992;60(10):3986–3993. doi: 10.1128/iai.60.10.3986-3993.1992
   PubMed Web of Science ®Google Scholar
• Brown EJ. Interaction of gram-positive microorganisms with complement. Curr Top Microbiol Immunol. 1985;121:159–187. doi: 10.1007/978-3-642-45604-6_8
   PubMed Web of Science ®Google Scholar
• Law SK. C3 receptors on macrophages. J Cell Sci Suppl. 1988(9Supplement_9):67–97. doi: 10.1242/jcs.1988.supplement_9.4
   Google Scholar
• O’Shea JJ, Brown EJ, Seligmann BE, et al. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J Immunol. 1985;134(4):2580–2587. doi: 10.1056/NEJM200104053441406
   PubMed Web of Science ®Google Scholar
• Walport MJ, Mackay IR, Rosen FS. Complement. first of two parts. N Engl J Med. 2001;344(14):1058–1066. doi: 10.1056/NEJM200104053441406
   PubMed Web of Science ®Google Scholar